---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-003305"
form_type: "8-K"
ticker: null
cik: "0001783032"
company_name: "Elevation Oncology, Inc."
filed_at: "2025-03-19T23:59:59+00:00"
generated_at: "2026-05-24T11:58:44.856232+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Elevation Oncology transfers to Nasdaq Capital Market; granted 180-day bid price cure period

## Summary
- Transfer from Nasdaq Global Select to Nasdaq Capital Market effective March 21, 2025.
- Company noncompliant with $1.00 minimum bid price for 30 consecutive days as of Sept 2024.
- Nasdaq granted additional 180 days, until September 15, 2025, to regain compliance.
- To cure, closing bid price must hit $1.00 for 10 consecutive business days by that date.
- Company will monitor and consider options including a reverse stock split if needed.

## SEC filing metadata
- accession: 0001558370-25-003305
- form_type: 8-K
- cik: 0001783032
- company_name: Elevation Oncology, Inc.
- filed_at: 2025-03-19T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1783032/000155837025003305/0001558370-25-003305-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1783032/000155837025003305/elev-20250319x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-003305
- JSON: https://secwatch.observer/filing/0001558370-25-003305.json
- Plain text: https://secwatch.observer/filing/0001558370-25-003305.txt

## Key facts
- Listing & Compliance Notices
  Elevation Oncology, Inc. received a nasdaq extension granted notice regarding minimum bid price.
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  source text: March 19, 2025, the Nasdaq Listing Qualifications department approved the Company’s request to transfer the listing of the Company’s shares of common stock from The Nasdaq Global Select Market to The Nasdaq Capital Market. The transfer will take effect at the opening of business on March 21, 2025. The transfer of the Company’s listing to The Nasdaq Capital Market is not expected to have any immediate effect on trading in shares of the Company’s common stock. The Company’s shares will continue to trade uninterruptedly under the symbol “ELEV.” The Nasdaq Capital Market operates in substantially
  evidence_url: https://www.sec.gov/Archives/edgar/data/1783032/000155837025003305/0001558370-25-003305-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.